JPML Centralizes J&J Invokana Unit Litigation In N.J.
Fifty-five lawsuits against a Johnson & Johnson unit over claims that the company failed to adequately test its Invokana diabetes drug and warn consumers about the risk of medical problems have...To view the full article, register now.
Already a subscriber? Click here to view full article